207 results on '"Grills I"'
Search Results
2. Modelling of pulmonary function test changes after stereotactic body radiotherapy for stage I NSCLC: 99PD
3. MO-0472 Prospective trial of functional lung avoidance radiation for lung cancer: quality of life report
4. PO-1759: A dose validation tool prior to proton and photon treatment in spine SRS
5. OC-0671 Which planning strategy is better for Head and Neck Cancer: PTV based or CTV based robust IMPT ?
6. OC-0603: Spot scanning arc therapy for lung cancer: dosimetric improvement and interplay effect mitigation
7. PO-0916: Explore the future of of proton hypo-fractionation treatment - Spot-scanning Proton Arc therapy
8. PV-0042: SBRT for peripheral lung tumors >5 cm: first results of the multicenter phase I/II VOLUMES trial
9. MA 13.09 Toxicity and Second Primary Lung Cancers in Late Survivors Following Lung SBRT
10. 99PD: Modelling of pulmonary function test changes after stereotactic body radiotherapy for stage I NSCLC
11. OC-0399: Dose to heart substructures is associated with non-cancer death after SBRT in stage I NSCLC patients
12. OC-0135: Can we select stage I NSCLC patients at high risk for early death prior to SBRT treatment?
13. TH-AB-304-06: Investigation of Fractionation Issues in NTCP Modeling of Pneumonitis: An Analysis of Common NTCP Models for Hypo-Fractionated and Standard-Fractionated Data
14. PO-0907: TCP modeling in a large cohort of NSCLC patients inclusive of geometric uncertainties
15. Propensity Score Matched-Pair Analysis of Interstitial Multicatheter Versus Balloon-Based Accelerated Partial Breast Irradiation, Stratified by ASTRO Guidelines
16. A multi-national report on methods for institutional credentialing for spine radiosurgery
17. Time Interval Between Staging FDG Positron Emission Tomography (PET) and Initiation of Stereotactic Lung Radiotherapy (SBRT) Impacts the Risk of Recurrence and Metastasis in Non-small Cell Lung Cancer (NSCLC)
18. Poor Pulmonary Function is Not Associated with Increased Rates of Toxicity or Decreased Overall Survival After Stereotactic Body Radiotherapy for Early Stage Non-Small Cell Lung Cancer: Results of a Multi-institutional Analysis
19. A Multi-national Pooled Analysis of 434 Cases of Stage I Non-small Cell Lung Cancer (NSCLC) Treated with Volumetrically Image-guided Stereotactic Lung Radiotherapy: Results from the Elekta Collaborative Lung Research Group
20. Substantial Dose-response Relationship with Clinical Outcome for Lung Stereotactic Body Radiotherapy (SBRT) Delivered via Online Image Guidance
21. Re-irradiation With Stereotactic Radiosurgery Treatment for Spinal Metastases: Results From an International Multicenter Database
22. Improved Modeling of Radiation Pneumonitis Risk in Lung SBRT by Incorporating a Local Dose–Effect Relation for Perfusion Reduction
23. SU-E-T-408: Dosimetric Effect of Intrafraction Motion in Spine SRS: A Retrospective Study
24. Impact of the Number of Cautionary/Unsuitable Risk Factors on Outcomes Following Accelerated Partial Breast Irradiation
25. Clinical Target Volumes for Accelerated Partial Breast Irradiation: Are They Equivalent? A Volumetric Analysis
26. Image Guided Adaptive Radiation Therapy for Prostate Cancer: Toxicity Comparison for 3D Conformal Versus Intensity Modulated Beams
27. Clinical Outcomes and Toxicity After Stereotactic Body Radiation Therapy (SBRT) With or Without Adjuvant Chemotherapy for Stage I Non-small Cell Lung Cancer (NSCLC)
28. Radio-inducible Adaptive Response Effect on Hypofractionation of Lung Cancer Radiation Therapy
29. Outcomes and Toxicities of 3-dimensional Conformal Accelerated Partial Breast Irradiation
30. Evaluation of Breathing Excursion Variability in Lung Cancer Patients During Conventional and Hypofractionated Radiation Therapy
31. No Difference in Outcome Between Biopsied Versus Nonbiopsied Early Stage Medically Inoperable Non-small Cell Lung Cancer Patients Treated With Volumetric Image Guided Stereotactic Body Radiation Therapy (SBRT): Analysis of a Large Multi-institutional Database
32. Variability in Spine Radiosurgery Treatment Planning -- Results of an International Multi-institutional Study
33. A Multi-national Report on Methods of Image-guided Stereotactic Body Radiotherapy and Radiosurgery for Vertebral Metastases
34. Quality of Life and Audiologic Changes in Patients treated with Gamma Knife Stereotactic Radiosurgery for Vestibular Schwannoma
35. Comparing The Effect Of Higher Activity (Source Strength) Of Ir-192 versus Lower Activity on Toxicity And Clinical Outcomes of Prostate High Dose Rate (HDR) Brachytherapy (BT)
36. NTCP Modeling for Radiation Pneumonitis after SBRT for Malignant Pulmonary Lesions: Results of a Multi-institutional Analysis
37. Outcomes by breast cancer subtype in patients treated with accelerated partial breast irradiation.
38. 618 poster FOUR-YEAR RESULTS USING BALLOON BASED BRACHYTHER-APY TO DELIVER APBI WITH A TWO-DAY DOSE FRACTIONATION SCHEDULE
39. WHAT IS THE THRESHOLD DOSE FOR PROCESSES THAT LEAD TO THE DEVELOPMENT OF RADIATION PNEUMONITIS?
40. Is the 1 cm CTV Margin Used in Breast Balloon Brachytherapy Equivalent to a 1.5 cm CTV Margin in External Beam Partial Breast Irradiation? A Deformable Registration Study
41. Comparison of MR Spectroscopy, MR perfusion, and Volume Modeling in Distinguishing Brain Tumor Recurrence from Radiation Necrosis
42. MicroPET/CT In Vivo Imaging of Orthotopic Human Glioblastoma Multiforme (hGBM) Murine Model
43. Time Interval between Staging FDG Positron Emission Tomography (PET) and Initiation of Stereotactic Lung Radiotherapy (SBRT) Impacts the Risk of Recurrence and Metastasis in Non-small Cell Lung Cancer (NSCLC)
44. Outcomes for Accelerated Partial Breast Irradiation in Ductal Carcinoma In Situ Patients
45. Comparison of IGRT Registration Strategies for Optimal Coverage of Primary Lung Tumors and Involved Nodes Based on Multiple 4D-CT Scans Obtained Throughout the RT Course
46. A multinational pooled analysis of 434 cases of stage I non-small cell lung cancer (NSCLC) treated with volumetrically image-guided (VIGRT) stereotactic lung radiotherapy (SBRT): Results from the Elekta Collaborative Lung Research Group.
47. A Multi-national Pooled Analysis of 434 Cases of Stage I Non-small Cell Lung Cancer (NSCLC) Treated with Volumetrically Image-guided Stereotactic Lung Radiotherapy: Results from the Elekta Collaborative Lung Research Group
48. Poor Pulmonary Function is Not Associated with Increased Rates of Toxicity or Decreased Overall Survival After Stereotactic Body Radiotherapy for Early Stage Non-Small Cell Lung Cancer: Results of a Multi-institutional Analysis
49. Time Interval Between Staging FDG Positron Emission Tomography (PET) and Initiation of Stereotactic Lung Radiotherapy (SBRT) Impacts the Risk of Recurrence and Metastasis in Non-small Cell Lung Cancer (NSCLC)
50. Substantial Dose-response Relationship with Clinical Outcome for Lung Stereotactic Body Radiotherapy (SBRT) Delivered via Online Image Guidance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.